The French Competition Authority authorizes the acquisition of Diagnovie by Biogroup

The French Competition Authority authorizes the acquisition of Diagnovie by Biogroup

Tactics has advised Biogroup in order to obtain clearance from the French Competition Authority for the acquisition of the Diagnovie group, active in the medical biology sector.

https://capitalfinance.lesechos.fr/amp/1406251